Shares of Ceapro Inc. (CVE:CZO – Get Free Report) were down 11.8% during trading on Tuesday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,849 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The company has a debt-to-equity ratio of 8.07, a current ratio of 8.54 and a quick ratio of 18.88. The company has a fifty day moving average price of C$0.22 and a 200 day moving average price of C$0.23. The company has a market capitalization of C$17.62 million, a P/E ratio of -3.75 and a beta of 1.38.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- What is the NASDAQ Stock Exchange?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is Short Interest? How to Use It
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Best Aerospace Stocks Investing
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
